FDA
-
-
-
-
-
-
-
Aethlon Medical publishes preclinical data on long COVID treatment device
-
-
-
-
-
-
-
Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes
-
-
-
-
-
-
-
Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
-
-
-
-
-
-
-
Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024
-
-
-
-
-
-
-
Aethlon Medical (AEMD) Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial
-
-
-
-
-
-
-
Aethlon Medical (AEMD) Receives Second Ethics Committee Approval for Hemopurifier Cancer Trial
-
-
-
-
-
-
-
The Hunt for Virus Treatments Continues Post Covid-19
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

